| Literature DB >> 28233740 |
María L Morales1, Carmen Sendra1, Manuel Romero-Gomez1.
Abstract
Hepatitis B virus infection seems to protect against steatosis and insulin resistance decreasing NAFLD. Metabolic syndrome has been associated with increased risk of disease progression to cirrhosis and liver cancer in hepatitis B. HBsAg seroclearance increased over time and it could be a confounding factor when analysing NAFLD and hepatitis B prevalence.Entities:
Keywords: HBeAg; HBsAg; Hepatitis B; NAFLD; NASH
Mesh：
Substances：
Year: 2017 PMID： 28233740 DOI： 10.5604/16652681.1231556
Source DB: PubMed Journal: Ann Hepatol ISSN： 1665-2681 Impact factor: 2.400